Shock Patients Treated With MCS Devices at Referral Hospitals Have Higher Risks Shock Patients Treated With MCS Devices at Referral Hospitals Have Higher Risks cmacahilig@crf.org Mon, 04/20/2026 - 16:32 Michael O'Riordan The study questions whether it may be best to wait to implant a support device until arriving at a level 1 shock center.

Shock Patients Treated With MCS Devices at Referral Hospitals Have Higher Risks

Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS Risk-factor control was poorer in female patients, who had a lower likelihood of reaching LDL and physical activity targets.

Women are less likely to adhere to post-acute coronary syndrome (ACS) medication than men with ACS. They are also less likely to meet the recommended LDL-cholesterol target and achieve goals for regular physical activity, based on data from the TEXTMEDS study. www.tctmd.com/news/women-l...

STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains cmacahilig@crf.org Mon, 04/20/2026 - 11:27 L.A. McKeown Early right-heart stabilization seems to be translating to better QoL and faster return of function, says Robert Lookstein.

STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains

In the latest On Record from #ACC2026, watch Lauren Eberly, Stephen Paul Juraschek, and Oluwabunmi Ogungbe discuss novel solutions to CVD with food-based interventions with Caitlin E. Cox. Full video available now: www.tctmd.com/videos/on-re...

No Sustained Benefit of High-Flow Nasal Oxygen After Cardiac Surgery: NOTACS Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

Patients who are given high-flow nasal oxygen therapy after cardiac surgery don't gain clinical benefits in the first 90 days compared with standard oxygen therapy, based on results from the multinational NOTACS trial. www.tctmd.com/news/no-sust...

Multifaceted Intervention Controls BP in Low-Income Hypertension Patients The IMPACTS-BP trial showed that SPRINT-like reductions in systolic BP are possible even in tough real-world scenarios.

Blood pressure levels in low-income patients are reduced and managed when an asystematic, multipronged intervention is implemented, according to results from the IMPACTS-BP trial. More here: www.tctmd.com/news/multifa...

Higher Stroke Risk Seen With Pulsed-Field vs Radiofrequency Ablation Higher Stroke Risk Seen With Pulsed-Field vs Radiofrequency Ablation cmacahilig@crf.org Fri, 04/17/2026 - 16:20 Todd Neale The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher says.

Higher Stroke Risk Seen With Pulsed-Field vs Radiofrequency Ablation

April 2026 Dispatch for the CV Team April 2026 Dispatch for the CV Team cmacahilig@crf.org Fri, 04/17/2026 - 16:06 L.A. McKeown This month: dental costs and increased CVD risk, targeting fear of movement, workplace wellness programs, and more.

April 2026 Dispatch for the CV Team

For CVD Patients, Calcium Supplements May Spur Recurrent Events For CVD Patients, Calcium Supplements May Spur Recurrent Events cmacahilig@crf.org Fri, 04/17/2026 - 15:47 Caitlin E. Cox In line with earlier studies of the general population, the findings should encourage a thoughtful approach to calcium, experts say.

For CVD Patients, Calcium Supplements May Spur Recurrent Events

CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-analysis Among patients with a single CTO lesion, the study found an improvement in health status compared with medical therapy.

CTO PCI appears to greatly improve quality of life and reduce patient symptoms compared with long-term antianginal medication, based on combined analysis from two randomized trials. www.tctmd.com/news/cto-pci...

Watch Rachana Raghupathy and Kayle Shapero discuss how they got involved with advocacy and the ways their work is inspiring change with @yaelmaxwell.bsky.social on this Fellows Forum. www.tctmd.com/videos/fello...
#ACC2026

Financial Support After Hospital Discharge Boosts HFrEF Outcomes: FUND-HF Low-income patients receiving a debit card spent most of the money on things upstream of medical care like food and utilities.

In a pilot program, low-income patients with HFrEF who received financial aid after hospitalization had better medication adherence at one month compared with those whose costs were reimbursed after the study period, based on the FUND-HF trial. www.tctmd.com/news/financi...
#ACC2026

Trials Bolster LBBAP as an Alternative to Biventricular Pacing in CRT Trials Bolster LBBAP as an Alternative to Biventricular Pacing in CRT cmacahilig@crf.org Thu, 04/16/2026 - 11:07 Todd Neale Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.

Trials Bolster LBBAP as an Alternative to Biventricular Pacing in CRT

Now Published - OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding Now Published - OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding cmacahilig@crf.org Thu, 04/16/2026 - 10:28 Todd Neale The “truly groundbreaking” results expand the tool kit for secondary stroke prevention, one expert says.

Now Published - OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding

On this Fellows Forum, @yaelmaxwell.bsky.social sits down with Mary Norine Walsh, Aardra Rajendran, and Oksana Petrechko to talk about the field of cardio-OB, how fellows training has evolved, and what the future looks like. Watch the full video now: www.tctmd.com/videos/fello...

Hints of a Mortality Benefit With TTVR at 2 Years: TRISCEND II The data are limited but suggest the tricuspid valve procedure can do more than improve health status, researchers say.

TTVR remains safe and effective at two years for patients with severe TR. Not only does it improve quality of life, there appears to be evidence that it helps with mortality, though data is still limited, based on the results of the TRISCEND II trial. www.tctmd.com/news/hints-m...
#ACC2026

Real-world Evoque Data Reassure, but It’s Still Early Days With TTVR Real-world Evoque Data Reassure, but It’s Still Early Days With TTVR cmacahilig@crf.org Wed, 04/15/2026 - 13:30 Michael O'Riordan At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

Real-world Evoque Data Reassure, but It’s Still Early Days With TTVR

On this episode of Rox Heart Radio, Roxana Mehran and Ann Marie Navar discuss the 2026 dyslipidemia guidelines, covering the latest advice on LDL cholesterol, Lp(a), and more. Listen to the full episode now: www.tctmd.com/audio/rox-he...

Rox Heart Radio: The 2026 Dyslipidemia Guidelines Rox Heart Radio: The 2026 Dyslipidemia Guidelines cmacahilig@crf.org Wed, 04/15/2026 - 09:32 54 seconds ago Roxana Mehran speaks with Ann Marie Navar about the latest advice on LDL cholesterol, Lp(a), coronary artery calcium, and more.

Rox Heart Radio: The 2026 Dyslipidemia Guidelines

Matteo Montorfano, Master Operator, Dies at 60 Matteo Montorfano, Master Operator, Dies at 60 cmacahilig@crf.org Tue, 04/14/2026 - 16:40 Caitlin E. Cox Known for his skills as a clinician and educator, Montorfano contributed much to the interventional cardiology community.

Matteo Montorfano, Master Operator, Dies at 60

C-TRACT: Iliac Vein Stenting Results Look Good in Postthrombotic Syndrome C-TRACT: Iliac Vein Stenting Results Look Good in Postthrombotic Syndrome cmacahilig@crf.org Tue, 04/14/2026 - 16:16 L.A. McKeown The addition of stenting to usual care reduced symptoms and improved quality of life for patients with the condition after DVT.

C-TRACT: Iliac Vein Stenting Results Look Good in Postthrombotic Syndrome

DIG-RHD: Digoxin Effective in Rheumatic Heart Disease The benefit of digoxin was driven by reduced risk of new-onset or worsening HF hospitalizations, just like its benefit in HFrEF.

Treating patients with symptomatic rheumatic heart disease with digoxin may help modestly reduce the risk of all-cause mortality and new-onset or worsening HF, according to the DIG-RHD trial. www.tctmd.com/news/dig-rhd...
#ACC2026

Get ready for the world’s premier forum for #interventionalcardiology. #TCT2026 returns to San Diego this October! 🌎🎉

Our Program Development Committee is crafting a line-up of expert-led sessions to ignite innovation across cardiovascular care. Join us!  https://ow.ly/Zer750YCTss

#CardioSky

African Patients and Trialists Largely Left Out of CV Research The consistent underrepresentation of African populations in clinical studies is a ‘crisis of scientific validity,’ Bamba Gaye says.

African representation is severely lacking in the world's leading medical journals, especially in cardiology, based on data from a multiyear comparison study. This indicates a need to move from awareness to accountability for better representation in global research. www.tctmd.com/news/african...

Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS cmacahilig@crf.org Mon, 04/13/2026 - 15:39 Michael O'Riordan Risk-factor control was poorer in female patients, who had a lower likelihood of reaching LDL and physical activity targets.

Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS

Did you know you can register for One-Day Access to #NYValves2026? Your education on your schedule for one incredible day of valvular & structural heart care innovation.

Don’t let a busy schedule hold you back! Pick your day and secure your spot 👉 https://ow.ly/caIM50YCVK2

#CardioSky #MedSky

Disparities Widen Across Regions as Global Hypertension Burden Grows Though awareness, treatment, and control improved, prevalence worsened in low- and middle-income countries.

As the burden of hypertension increases globally, disparities between low- and high-income countries are widening, with prevalence worsening particularly in low- and middle-income countries. www.tctmd.com/news/dispari...

No Sustained Benefit of High-Flow Nasal Oxygen After Cardiac Surgery: NOTACS No Sustained Benefit of High-Flow Nasal Oxygen After Cardiac Surgery: NOTACS cmacahilig@crf.org Mon, 04/13/2026 - 12:46 L.A. McKeown Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

No Sustained Benefit of High-Flow Nasal Oxygen After Cardiac Surgery: NOTACS

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies Proven to prevent preeclampsia, aspirin needs to be better embedded in routine prenatal practice, researchers say.

Less than a quarter of women who are at high risk for preeclampsia are taking aspirin as a protective measure during pregnancy, despite the current recommended guidelines from the US Preventive Services Task Force (USPSTF). www.tctmd.com/news/despite...
#ACC2026

For women working in cardiology, how do you manage stress and complications during pregnancy while juggling a demanding career? Caitlin E. Cox sits down with Gina Lundberg, Karla Kurrelmeyer, and Estefania Oliveros to discuss some solutions in this On Record. #ACC2026 www.tctmd.com/videos/on-re...